Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...

Nutshell reports that transitioning from spreadsheets to CRM can be challenging due to data quality issues, longer timelines, ...

MHT CET PCB Hall Ticket 2026 released at cetcell.mahacet.org. Candidates can download city intimation slip to check exam date ...

Using the tool kit, the team then achieved resolution high enough to visualize endosomes shuttling cargo into the cell’s ...

A two-day workshop titled “Workshop on Preparation for Accreditation” was held on Monday and Wednesday at the conference room ...

With two decades of dedicated focus in this field, Cloud-Clone has evolved from early-stage exploration into a globally ...

How could relapse in leukemia after CAR T treatment—a problem that still affects between 30–60% of patients—be prevented? One major driver is antigen escape: leukemia cells can dial down or lose the ...

Chimeric antigen receptor T (CAR T) cell therapy represents a milestone in leukemia treatment. CAR T works by genetically engineering a chimeric antigen receptor on the surface of the patient's T ...

WUHAN, HUBEI PROVINCE, CHINA, February 15, 2026 /EINPresswire.com/ — In the complex landscape of life science research, selecting the right cellular model is a ...

Scientists in China have unveiled a breakthrough way to mass-produce powerful cancer-fighting immune cells in the lab. By engineering early-stage stem cells from cord blood—rather than trying to ...